ArticleAnnals of translational medicine2019
Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors.
Hirva Mamdani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it